REFERENCES | 16 |
| | |
Exercise Training Programs for Patients with Intermittent Claudication | 21 |
| | |
BENEFITS OF SUPERVISED TREADMILL EXERCISE PROGRAMS IN PATIENTS WITH PAD | 22 |
| | |
EXERCISE REHABILITATION AND FUNCTIONAL OUTCOMES IN PERSONS WITH PERIPHERAL ARTERIAL DISEASE AND INTERMITTE... | 24 |
| | |
SAFETY OF EXERCISE REHABILITATION | 25 |
| | |
MAINTENANCE OF GAINS ACHIEVED DURING EXERCISE REHABILITATION IN PAD | 26 |
| | |
SELFDIRECTED WALKING EXERCISE AND RATES OF FUNCTIONAL DECLINE IN PERIPHERAL ARTERIAL DISEASE | 27 |
| | |
MECHANISMS BY WHICH WALKING EXERCISE INCREASES PAINFREE AND MAXIMAL WALKING DISTANCE IN INTERMITTENT CLA... | 28 |
| | |
UPPER AND LOWER LIMB AEROBIC EXERCISE IN PERIPHERAL ARTERIAL DISEASE | 29 |
| | |
LOWER EXTREMITY STRENGTH TRAINING IN PERIPHERAL ARTERIAL DISEASE | 30 |
| | |
POTENTIAL BARRIERS TO PARTICIPATION IN EXERCISE TRAINING PROGRAMS | 31 |
| | |
CONCLUSION | 32 |
| | |
Value of Preoperative Duplex Scanning in Planning Infrainguinal Bypass | 35 |
| | |
REFERENCES | 40 |
| | |
Infrainguinal Graft Duplex Surveillance Detection and Treatment of Graft Threatening Lesions | 43 |
| | |
POSTOPERATIVE VEIN GRAFT EVALUATION | 44 |
| | |
RATIONALE FOR SURVEILLANCE | 45 |
| | |
GRAFT REVISION | 50 |
| | |
INTERVENTION FOR GRAFT STENOSIS | 52 |
| | |
ARTERIAL DISEASE PROGRESSION | 54 |
| | |
REFERENCES | 55 |
| | |
Statin Management for Vascular Surgery Patients | 59 |
| | |
WHAT ARE STATINS? | 60 |
| | |
DIRECT BENEFICIAL EFFECTS OF STATINS FOR VASCULAR PATIENTS | 61 |
| | |
STATIN USE IN A VASCULAR PRACTICE | 64 |
| | |
COMPLICATIONS WITH STATIN USE | 65 |
| | |
REFERENCES | 66 |
| | |
Antiplatelet Medication in Patients with Vascular Disease and Following Interventions | 69 |
| | |
ROLE OF PLATELETS IN ATHEROSCLEROSIS ARTERIAL THROMBOSIS BYPASS GRAFT OCCLUSION AND RESTENOSIS AFTER PERCU... | 70 |
| | |
ANTIPLATELET AGENTS | 71 |
| | |
PROTECTION FROM MAJOR CARDIOVASCULAR MORBIDITY MYOCARDIAL INFARCTION STROKE OR DEATH | 72 |
| | |
ANTIPLATELET EFFECT ON BYPASS GRAFT PATENCY | 74 |
| | |
ANTIPLATELET EFFECT FOLLOWING PERIPHERAL PERCUTANEOUS INTERVENTION | 75 |
| | |
REFERENCES | 77 |
| | |
The Use of Antithrombins as Alternatives to Conventional Anticoagulation | 79 |
| | |
THROMBOGENESIS | 80 |
| | |
SUMMARY | 84 |
| | |
Is RevascularizationLimb Salvage Always the Best Treatment for Patients with Critical Limb Ischemia? | 87 |
| | |
PROGNOSIS OF CLI | 88 |
| | |
FUNCTIONAL STATUS OF PATIENTS WITH CLI | 89 |
| | |
ALTERNATIVES TO REVASCULARIZATION FOR CLI | 91 |
| | |
POSSIBLE APPROACHES TO CURRENT TREATMENT OF CLI | 92 |
| | |
REFERENCES | 93 |
| | |
Burning Bridges Is the Application of Emerging Technologies Deleterious to the Care of the Vascular Patient and the Nations Financial Resources? | 95 |
| | |
THE SURGICAL SAFETY NET ARGUMENT | 96 |
| | |
EAST CAROLINA EXPERIENCE WITH SECONDARY BYPASS | 97 |
| | |
CONCLUSIONS | 100 |
| | |
Percutaneous Intervention for Limb Ischemia | 103 |
| | |
Endovascular Therapy is the Preferred Initial Treatment for all Lower Extremity Revascularization | 105 |
| | |
NATURAL HISTORY | 106 |
| | |
PATIENT LONGEVITY WITH LOWER EXTREMITY REVASCULARIZATION | 107 |
| | |
PERIPROCEDURAL COMPLICATIONS | 108 |
| | |
FUNCTIONAL OUTCOME | 109 |
| | |
PATENCY AND REINTERVENTION | 110 |
| | |
WHAT IS THE CONSEQUENCE OF FAILURE? | 111 |
| | |
REFERENCES | 112 |
| | |
Techniques to Treat Chronic Total Iliac Artery Occlusions | 115 |
| | |
LESION CHARACTERISTICS AND PATIENT SELECTION | 116 |
| | |
DETERMINING THE SITE OF ACCESS | 117 |
| | |
CROSSING TOTAL OCCLUSIONS | 118 |
| | |
RECONSTRUCTION OF ILIAC CTOs | 123 |
| | |
COMPLICATIONS OF ILIAC ARTERY ANGIOPLASTY AND STENTING | 124 |
| | |
CONCLUSIONS | 125 |
| | |
Angioplastybased Infrainguinal Percutaneous Interventions | 127 |
| | |
CLINICAL SERIES | 128 |
| | |
INFRAPOPLITEAL PTA RESULTS | 130 |
| | |
NITINOL SELFEXPANDING STENTS | 131 |
| | |
NOVEL TECHNOLOGIES AND TECHNIQUES FOR INFRAINGUINAL PERCUTANEOUS INTERVENTIONS | 132 |
| | |
BIODEGRADABLE STENTS | 135 |
| | |
CONCLUSIONS | 136 |
| | |
REFERENCES | 137 |
| | |
Remote Superficial Femoral Artery Endarterectomy | 139 |
| | |
RSFAE PHASE | 140 |
| | |
RESULTS | 141 |
| | |
RSFAE AND DISTAL ASPIRE STENTING | 142 |
| | |
DISCUSSION | 143 |
| | |
RSFAE AND DISTAL VEIN BYPASS | 145 |
| | |
CONCLUSION | 146 |
| | |
Subintimal Angioplasty for the Treatment of Lower Extremity Ischemia | 149 |
| | |
TECHNIQUE | 150 |
| | |
CASE DESCRIPTIONS | 151 |
| | |
DISCUSSION | 155 |
| | |
SUMMARY | 158 |
| | |
The Role of Atherectomy in Lower Extremity Arterial Occlusive Disease | 161 |
| | |
STUDIES | 164 |
| | |
COMPLICATIONS | 166 |
| | |
APPLICATIONS | 167 |
| | |
Open Surgical Revascularization in the Endovascular Era | 169 |
| | |
Improving Lower Extremity Bypass Patency | 171 |
| | |
PATIENT SELECTION | 173 |
| | |
CURRENT LOWER EXTREMITY BYPASS TECHNIQUES | 175 |
| | |
MEDICAL ADJUNCTS | 177 |
| | |
A COMPREHENSIVE PROGRAM | 178 |
| | |
REFERENCES | 179 |
| | |
A 20year Experience with Infrapopliteal Prosthetic Graft | 183 |
| | |
DATA ANALYSIS | 184 |
| | |
RESULTS | 186 |
| | |
INFRAPOPLITEAL ANGIOPLASTY FOR CRITICAL LIMB ISCHEMIA | 190 |
| | |
SUMMARY | 192 |
| | |
Lower Limb Revascularization in Patients with Diabetes Mellitus | 195 |
| | |
ARTERIAL IMAGING | 199 |
| | |
STRATEGIES FOR DISTAL BYPASS | 200 |
| | |
PROFUNDA FEMORIS ARTERY | 203 |
| | |
PROCEDURES ON THE PROFUNDA | 204 |
| | |
REFERENCES | 205 |
| | |
Vein Bypass Grafts to the Dorsalis Pedis Artery | 207 |
| | |
REFERENCES | 213 |
| | |
Unusual Exposure for Lower Extremity Revascularization | 215 |
| | |
LATERAL APPROACHES | 217 |
| | |
POSTERIOR APPROACH | 220 |
| | |
COMMENTS | 223 |
| | |
REFERENCES | 224 |
| | |
Surgical Management of Femoral and Popliteal Artery Aneurysms | 225 |
| | |
POPLITEAL ARTERY ANEURYSM | 226 |
| | |
FEMORAL ANEURYSM | 232 |
| | |
FEMORAL ARTERY PSEUDOANEURYSM | 234 |
| | |
REFERENCES | 238 |
| | |
Advances in Wound Care and Amputation | 241 |
| | |
The Healing of Infection Ulceration and Minor Amputation Revascularization in Patients with Diabetes | 243 |
| | |
SURGICAL APPROACH TO THE PATIENT WITH DIABETES MELLITUS | 245 |
| | |
TISSUE LOSS AND ULCERATION | 246 |
| | |
MINOR AMPUTATION | 247 |
| | |
CONCLUSIONS | 248 |
| | |